As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Jobs
Growth
Financials
Overview
BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.
News
Lilly files six lawsuits in bid to shut down 'black market' for retatrutide
Ahead of an approval filing, the drugmaker is amping up a fight against sellers who claim to offer versions of its highly anticipated "triple-G" weight loss medicine.
Read more
Report
Psychedelics developer Definium scores more positive data for LSD pill
Results from a late-stage study focused on generalized anxiety disorder were a "clean win" to analysts, who believe Definium has a drug with multibillion-dollar sales potential.
Read more
Report
Silence cashes in on 'differentiated' data; UK reaffirms support for childhood vaccines
Some analysts believe Silence's polycythemia vera drug could be superior to a closely watched Takeda medicine. Elsewhere, the FDA spurned a radiopharmaceutical and AbCellera shares climbed to levels not seen since 2023.
Read more
Report
Boulevard starts up with $65M to pursue targeted autoimmune drugs
Co-founded by pioneering researcher Georg Schett and ex-Sanofi CSO Frank Nestle, the startup is advancing a trio of multifaceted antibodies with the potential to treat several immune diseases.
Read more
Report
Neurocrine Biosciences rare disease drug possibly tied to safety issues, experts say
Vykat XR, a newly approved drug sold by Neurocrine Biosciences, is possibly tied to a series of deaths and cases of severe side effects, experts say.
Read more
Report
Premium access
Upgrade to see all 29 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Jobs
No jobs available at this time.
